153 related articles for article (PubMed ID: 36729317)
1. Scale down and optimized automated production of [68Ga]68Ga-DOTA-ECL1i PET tracer targeting CCR2 expression.
Migliari S; Scarlattei M; Baldari G; Ruffini L
EJNMMI Radiopharm Chem; 2023 Feb; 8(1):3. PubMed ID: 36729317
[TBL] [Abstract][Full Text] [Related]
2. ECL1i, d(LGTFLKC), a novel, small peptide that specifically inhibits CCL2-dependent migration.
Auvynet C; Baudesson de Chanville C; Hermand P; Dorgham K; Piesse C; Pouchy C; Carlier L; Poupel L; Barthélémy S; Felouzis V; Lacombe C; Sagan S; Chemtob S; Quiniou C; Salomon B; Deterre P; Sennlaub F; Combadière C
FASEB J; 2016 Jun; 30(6):2370-81. PubMed ID: 26979087
[TBL] [Abstract][Full Text] [Related]
3. PET-based Imaging of Chemokine Receptor 2 in Experimental and Disease-related Lung Inflammation.
Liu Y; Gunsten SP; Sultan DH; Luehmann HP; Zhao Y; Blackwell TS; Bollermann-Nowlis Z; Pan JH; Byers DE; Atkinson JJ; Kreisel D; Holtzman MJ; Gropler RJ; Combadiere C; Brody SL
Radiology; 2017 Jun; 283(3):758-768. PubMed ID: 28045644
[TBL] [Abstract][Full Text] [Related]
4. Molecular Imaging Visualizes Recruitment of Inflammatory Monocytes and Macrophages to the Injured Heart.
Heo GS; Kopecky B; Sultan D; Ou M; Feng G; Bajpai G; Zhang X; Luehmann H; Detering L; Su Y; Leuschner F; Combadière C; Kreisel D; Gropler RJ; Brody SL; Liu Y; Lavine KJ
Circ Res; 2019 Mar; 124(6):881-890. PubMed ID: 30661445
[TBL] [Abstract][Full Text] [Related]
5. Targeted PET Imaging of Chemokine Receptor 2-Positive Monocytes and Macrophages in the Injured Heart.
Heo GS; Bajpai G; Li W; Luehmann HP; Sultan DH; Dun H; Leuschner F; Brody SL; Gropler RJ; Kreisel D; Lavine KJ; Liu Y
J Nucl Med; 2021 Jan; 62(1):111-114. PubMed ID: 32444372
[TBL] [Abstract][Full Text] [Related]
6. CCR2 Positron Emission Tomography for the Assessment of Abdominal Aortic Aneurysm Inflammation and Rupture Prediction.
English SJ; Sastriques SE; Detering L; Sultan D; Luehmann H; Arif B; Heo GS; Zhang X; Laforest R; Zheng J; Lin CY; Gropler RJ; Liu Y
Circ Cardiovasc Imaging; 2020 Mar; 13(3):e009889. PubMed ID: 32164451
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive Imaging of CCR2
Liu Y; Li W; Luehmann HP; Zhao Y; Detering L; Sultan DH; Hsiao HM; Krupnick AS; Gelman AE; Combadiere C; Gropler RJ; Brody SL; Kreisel D
Am J Transplant; 2016 Oct; 16(10):3016-3023. PubMed ID: 27273836
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, validation and quality controls of [68Ga]-DOTA-Pentixafor for PET imaging of chemokine receptor CXCR4 expression.
Sammartano A; Migliari S; Scarlattei M; Baldari G; Ruffini L
Acta Biomed; 2020 Jul; 91(4):e2020097. PubMed ID: 33525262
[TBL] [Abstract][Full Text] [Related]
9. Chemokine Receptor 2-targeted Molecular Imaging in Pulmonary Fibrosis. A Clinical Trial.
Brody SL; Gunsten SP; Luehmann HP; Sultan DH; Hoelscher M; Heo GS; Pan J; Koenitzer JR; Lee EC; Huang T; Mpoy C; Guo S; Laforest R; Salter A; Russell TD; Shifren A; Combadiere C; Lavine KJ; Kreisel D; Humphreys BD; Rogers BE; Gierada DS; Byers DE; Gropler RJ; Chen DL; Atkinson JJ; Liu Y
Am J Respir Crit Care Med; 2021 Jan; 203(1):78-89. PubMed ID: 32673071
[No Abstract] [Full Text] [Related]
10. Chemokine Receptor 2 Targeted PET/CT Imaging Distant Metastases in Pancreatic Ductal Adenocarcinoma.
Zhang X; Detering L; Heo GS; Sultan D; Luehmann H; Li L; Somani V; Lesser J; Tao J; Kang LI; Li A; Lahad D; Rho S; Ruzinova MB; DeNardo DG; Dehdashti F; Lim KH; Liu Y
ACS Pharmacol Transl Sci; 2024 Jan; 7(1):285-293. PubMed ID: 38230294
[TBL] [Abstract][Full Text] [Related]
11. Chemokine Receptor 2 Is A Theranostic Biomarker for Abdominal Aortic Aneurysms.
Elizondo-Benedetto S; Sastriques-Dunlop S; Detering L; Arif B; Heo GS; Sultan D; Luehmann H; Zhang X; Gao X; Harrison K; Thies D; McDonald L; Combadière C; Lin CY; Kang Y; Zheng J; Ippolito J; Laforest R; Gropler RJ; English SJ; Zayed MA; Liu Y
medRxiv; 2023 Nov; ():. PubMed ID: 37986880
[TBL] [Abstract][Full Text] [Related]
12. Fully-automated production of [
Spreckelmeyer S; Schulze O; Brenner W
EJNMMI Radiopharm Chem; 2020 Feb; 5(1):8. PubMed ID: 32107654
[TBL] [Abstract][Full Text] [Related]
13. Automated Synthesis of 68Ga-DOTA-TOC with a Cationic Purification System: Evaluation of Methodological and Technical Aspects in Routine Preparations.
Uccelli L; Boschi A; Cittanti C; Martini P; Lodi L; Zappaterra E; Romani S; Zaccaria S; Cecconi D; Rambaldi I; Santi I; Panareo S; Giganti M; Bartolomei M
Curr Radiopharm; 2018; 11(2):130-137. PubMed ID: 29745348
[TBL] [Abstract][Full Text] [Related]
14. Infrared-based module for the synthesis of 68Ga-labeled radiotracers.
Azhdarinia A; Yang DJ; Chao C; Mourtada F
Nucl Med Biol; 2007 Jan; 34(1):121-7. PubMed ID: 17210469
[TBL] [Abstract][Full Text] [Related]
15. Assessment of ultrasmall nanocluster for early and accurate detection of atherosclerosis using positron emission tomography/computed tomography.
Sultan D; Li W; Detering L; Heo GS; Luehmann HP; Kreisel D; Liu Y
Nanomedicine; 2021 Aug; 36():102416. PubMed ID: 34147662
[TBL] [Abstract][Full Text] [Related]
16. Comparative gallium-68 labeling of TRAP-, NOTA-, and DOTA-peptides: practical consequences for the future of gallium-68-PET.
Notni J; Pohle K; Wester HJ
EJNMMI Res; 2012 Jun; 2(1):28. PubMed ID: 22682112
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors.
Kowalski J; Henze M; Schuhmacher J; Mäcke HR; Hofmann M; Haberkorn U
Mol Imaging Biol; 2003; 5(1):42-8. PubMed ID: 14499161
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Quality Control of the ITG 68Ge/68Ga Generator and Synthesis of 68Ga-DOTATOC and 68Ga-PSMA-HBED-CC for Clinical Imaging.
Amor-Coarasa A; Schoendorf M; Meckel M; Vallabhajosula S; Babich JW
J Nucl Med; 2016 Sep; 57(9):1402-5. PubMed ID: 27103024
[TBL] [Abstract][Full Text] [Related]
19. Automated synthesis and quality control of [
Daniel T; Balouzet Ravinet C; Clerc J; Batista R; Mouraeff Y
EJNMMI Radiopharm Chem; 2023 Feb; 8(1):4. PubMed ID: 36749409
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of a Scale-down Production of [
Migliari S; Sammartano A; Scarlattei M; Baldari G; Janota B; Bonadonna RC; Ruffini L
Curr Radiopharm; 2022; 15(1):63-75. PubMed ID: 33687908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
